Kumar, Sunita M.
Simm, Peter J.
De Silva l, Manikkuwadura
Gorelik, Alexandra
Freeman, Jeremy L.
Mackay, Mark T.
Ahmad, Baemisla Shiek
Petty, Sandra J.
Wark, John D.
Article History
Received: 5 January 2021
Accepted: 18 March 2021
First Online: 7 April 2021
Declarations
:
: J.L. Freeman reports having received consulting fees from Eisai Australia, Liva Nova Australia and from UCB Australia. J.D. Wark has received grants-in-aid for unrelated projects in epilepsy treatment by UCB Pharma and Novartis. S.M. Kumar, P.J. Simm, M. De Silva, A. Gorelik, M.T. Mackay, B. Shiek Ahmad and S.J. Petty reports no disclosures.
: The study was approved by the Royal Children’s Hospital Human Research Ethics Committee (HREC35100A).
: Written informed consent was obtained from participants over the age of 18 years and from parents or guardians of participants under the age of 18 years.
: All authors have consented to the submitted manuscripts publication.
: Human rights were followed as the study was conducted under the approval of our HREC. Animal rights were not relevant as this is a study in humans.